Skip to main content
. Author manuscript; available in PMC: 2015 Nov 3.
Published in final edited form as: Am J Kidney Dis. 2014 Nov 5;65(4):592–602. doi: 10.1053/j.ajkd.2014.10.015

Table 3.

Association between kidney function recovery and baseline features.

Unadjusted associations between baseline characteristics and Kidney function recovery at 6 months
Entire Cohort (n=281) Subgroup excluding CKD5
(n=225)

Predictors of Kidney function recovery at 6
months*
Hazard Ratio
(95% CI)
p Hazard Ratio
(95% CI)
p
Age, per 5 year 0.93 (0.85–1.01) 0.1 0.94 (0.87–1.03) 0.2
Female gender 1.43 (0.80–2.50) 0.2 1.39 (0.78–2.44) 0.3
Caucasian race 2.19 (0.80–9.02) 0.1 2.11 (0.78–8.67) 0.2
Diabetes mellitus 0.64 (0.36–1.12) 0.1 0.58 (0.33–1.03) 0.06
Coronary artery disease 0.67 (0.37–1.18) 0.2 0.70 (0.39–1.24) 0.2
Heart failure 0.36 (0.19–0.67) <0.001 0.39 (0.20–0.71) 0.002
Prior outpatient nephrology evaluation 0.21 (0.09–0.41) <0.001 0.31 (0.14–0.61) 0.004
Charlson comorbidity score
Charlson score, per 1 point 0.84 (0.77–0.91) <0.001 0.85 (0.78–0.93) <0.001
Charlson score ≥8 0.37 (0.19–0.68) <0.001 0.41 (0.21–0.75) 0.004
Hospital
ICU vs. non-ICU first dialysis location 1.96 (1.11–3.44) 0.02 1.59 (0.90–2.79) 0.1
Time between admission and RRT start, per 1 day 1.02 (0.98–1.06) 0.3 1.01 (0.96–1.05) 0.8
Time between RRT start and discharge, per 1 day 0.99 (0.98–1.01) 0.8 0.99 (0.98–1.00) 0.4
Length of hospital stay, per 1 day 1.00 (0.99–1.01) 0.9 1.00 (0.98–1.00) 0.5

Incident HD year Incident HD year 2006 1.0 (REFERENT) 1.0 (REFERENT)
Incident HD year 2007 2.87 (1.15–8.12) 0.02 3.11 (1.25–8.79) 0.01
Incident HD year 2008 3.45 (1.43–9.57) 0.005 3.20 (1.33–8.86) 0.009
Incident HD year 2009 2.64 (1.02–7.58) 0.04 2.91 (1.13–8.37) 0.03

First Dialysis access
Catheters vs. Arteriovenous fistula/graft 4.95 (1.08–87.55) 0.03 2.76 (0.61–48.93) 0.2
Arteriovenous fistula/graft 1.0 (REFERENT) 1.0 (REFERENT)
Cuffed tunneled catheter 1.33 (0.23–25.07) 0.8 0.85 (0.15–16.11) 0.9
Non-cuffed, temporary catheter 8.22 (1.79–145.75) 0.003 4.11 (0.90–72.91) 0.08

Renal failure type subgroups
Acute kidney injury 1.0 (REFERENT) 1.0 (REFERENT)
Acute on chronic kidney disease 0.25 (0.14–0.45) <0.001 0.25 (0.14–0.45) <0.001
Chronic kidney disease stage 5 0.00 (0.00–0.04) <0.001 Not included
Acuity unknown 0.09 (0.01–0.31) <0.001 0.09 (0.01–0.31) <0.001

Sepsis/Postoperative ATN vs. other AKI & non-AKI 3.33 (1.90–5.93) <0.001 2.57 (1.46–4.58) 0.001
Acute and chronic pathology subgroups
Sepsis/Postoperative ATN pathology 1.0 (REFERENT) 1.0 (REFERENT)
Non-Sepsis/Postoperative ATN pathology 0.51 (0.28–0.89) 0.02 0.53 (0.30–0.92) 0.03
Chronic pathology only 0.00 (0.00–0.07) <0.001 0.0 (0.00–0.00) <0.001

GFR Measurements: n= 253 n= 197
eGFR, per 10 ml/min/1.73m2 1.30 (1.21–1.40) <0.001 1.24 (1.15–1.34) <0.001
eGFR ≥30 ml/min/1.73m2 7.50 (3.78–16.56) <0.001 4.40 (2.22–9.71) <0.001

Multivariable-adjusted# associations between baseline characteristics and Kidney function recovery at 6
months

Predictors of Kidney function recovery at 6
months with acute and acute on chronic
Hazard Ratio
(95% CI)
p Hazard Ratio
(95% CI)
p

Variable (n=253) (n=197)

ICU location of first dialysis 0.83 (0.44–1.56) 0.6 - -
First dialysis access was a catheter 1.74 (0.36–31.34) 0.6 - -
Heart Failure 0.40 (0.19–0.78) 0.007 0.38 (0.19–0.74) 0.004
Sepsis/Postoperative ATN pathology 3.34 (1.83–6.24) <0.001 2.78 (1.54–5.13) <0.001
eGFR, per 10 ml/min/1.73m2 1.27 (1.16–1.39) <0.001 1.21 (1.11–1.32) <0.001
*

Subgroup analysis excluded CKD5 patients (n=56) with baseline eGFR<15 mL/min/1.73m2;

CKD: chronic kidney disease; eGFR: estimated glomerular filtration rate calculated from the CKD-Epi equation; Charlson score: Charlson comorbidity index score; AKI: acute kidney injury; HD: hemodialysis; ICU: intensive care unit; RRT: renal replacement therapy.

Sepsis/Postoperative ATN pathology includes all patients (AKI or Acute on Chronic injury) with sepsis or postoperative clinical or pathological etiologies.

#

Adjusted for each other variable in the model, excluding patients with unknown baseline eGFR in the subgroup analysis.